Predicting Adverse Drug Reactions Using Publicly Available PubChem BioAssay Data

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Clinical pharmacology and therapy

• Publication date

  2011-07-01

• Fields of study

  Medicine, Chemistry, Computer Science

• Identifiers
  DOI 10.1038/clpt.2011.81PMID 21613989PMCID PMC3464971
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MedWatch

  2013cited by this paper
• Clioquinol: Review of its Mechanisms of Action and Clinical Uses in Neurodegenerative Disorders

  2012cited by this paper
• MMP13 mediates cell cycle progression in melanocytes and melanoma cells: in vitro studies of migration and proliferation

  2010cited by this paper
• Systematic analysis of genome-wide fitness data in yeast reveals novel gene function and drug action

  2010cited by this paper
• Prediction of Adverse Drug Reactions Using Decision Tree Modeling

  2010cited by this paper
• Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death

  2010cited by this paper
• Signal integration by JNK and p38 MAPK pathways in cancer development

  2009cited by this paper
• An overview of the PubChem BioAssay resource

  2009cited by this paper
• Data‐Driven Methods to Discover Molecular Determinants of Serious Adverse Drug Events

  2009cited by this paper
• A survey of across-target bioactivity results of small molecules in PubChem

  2009cited by this paper
• Diacerein inhibits the synthesis of resorptive enzymes and reduces osteoclastic differentiation/survival in osteoarthritic subchondral bone: a possible mechanism for a protective effect against subchondral bone remodelling

  2008cited by this paper
• PubChem: Integrated Platform of Small Molecules and Biological Activities

  2008cited by this paper
• In silico functional profiling of small molecules and its applications.

  2008cited by this paper
• Thiazolides inhibit growth and induce glutathione‐S‐transferase Pi (GSTP1)‐dependent cell death in human colon cancer cells

  2008cited by this paper
• Adverse drug reactions and pharmacogenomics: recent advances.

  2008cited by this paper
• MedWatch–The FDA Safety Information and Adverse Event-Reporting Program

  2007cited by this paper
• Analysis of Pharmacology Data and the Prediction of Adverse Drug Reactions and Off‐Target Effects from Chemical Structure

  2007cited by this paper
• Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges

  2007cited by this paper
• In Silico Elucidation of the Molecular Mechanism Defining the Adverse Effect of Selective Estrogen Receptor Modulators

  2007cited by this paper
• Drug Development and the FDA's Critical Path Initiative

  2007cited by this paper
• Report of the IWGT working group on strategy/interpretation for regulatory in vivo tests II. Identification of in vivo-only positive compounds in the bone marrow micronucleus test.

  2007cited by this paper
• Analysis of drug-induced effect patterns to link structure and side effects of medicines

  2005cited by this paper
• ROCR: visualizing classifier performance in R

  2005cited by this paper
• Biological spectra analysis: Linking biological activity profiles to molecular structure.

  2005cited by this paper
• DrugBank: a comprehensive resource for in silico drug discovery and exploration

  2005cited by this paper
• Nitazoxanide: a new broad spectrum antiparasitic agent

  2004cited by this paper
• The Unified Medical Language System (UMLS): integrating biomedical terminology

  2004cited by this paper
• Expression of matrix metalloproteinases and their endogenous tissue inhibitors in skin lesions from patients with tuberous sclerosis.

  2004cited by this paper
• Association between glutathione-S-transferase GSTP1 genotypes, GSTP1 over-expression, and outcome in epithelial ovarian cancer

  2003cited by this paper
• An Experience Applying Reinforcement Learning in a Web-Based Adaptive and Intelligent Educational System

  2003cited by this paper
• Physicians' knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions.

  2002cited by this paper
• Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports

  2001cited by this paper
• Application of Technology: Design and Implementation of a National Clinical Trials Registry

  2000cited by this paper
• Anti-interleukin-1 effects of diacerein and rhein in human osteoarthritic synovial tissue and cartilage cultures.

  1999cited by this paper
• The Medical Dictionary for Regulatory Activities (MedDRA)

  1999cited by this paper
• Fatal toxic epidermal necrosis: responsibility of diacerein? A controversy.

  1998cited by this paper
• Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies.

  1998cited by this paper
• Tranilast inhibits collagen synthesis in normal, scleroderma and keloid fibroblasts at a late passage culture but not at an early passage culture.

  1995cited by this paper
• Glutathione-associated enzymes in anticancer drug resistance.

  1994cited by this paper
• New approach to the mechanism of antiasthmatic action of Tranilast.

  1990cited by this paper
• New approach to the mechanism of antiasthmatic action of Tranilast.

  1990cited by this paper
• The inhibition mechanism of histamine release by N-(3,4-dimethoxycinnamoyl) anthranilic acid.

  1985cited by this paper
• Ivermectin, a new broad-spectrum antiparasitic agent.

  1980cited by this paper
• Signal detection theory and ROC analysis

  1975cited by this paper
• A new look at the statistical model identification

  1974cited by this paper
• Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia

  1965cited by this paper
• Recent Advances

  year unknowncited by this paper

• Machine learning methods for predicting adverse drug events: A systematic review

  2025cites this paper
• Predicting Adverse Drug Reactions With Machine Learning

  2024cites this paper
• Advances in Predicting Drug Functions: A Decade-Long Survey in Drug Discovery Research

  2024cites this paper
• A Hybrid Neural Network Model with Entity-related Knowledge for Adverse Drug Reaction Detection

  2024cites this paper
• Non-Negative matrix factorization combined with kernel regression for the prediction of adverse drug reaction profiles

  2024cites this paper
• A Review on Adverse Drug Reaction Detection Techniques

  2024cites this paper
• An extensive survey on the use of supervised machine learning techniques in the past two decades for prediction of drug side effects

  2023cites this paper
• MLCNN‐COV: A multilabel convolutional neural network‐based framework to identify negative COVID medicine responses from the chemical three‐dimensional conformer

  2023cites this paper
• A Data-Driven Medical Decision Framework for Associating Adverse Drug Events with Drug-Drug Interaction Mechanisms

  2022cites this paper
• Reaching the Full Potential of Machine Learning in Mitigating Environmental Impacts of Functional Materials

  2022cites this paper
• idse-HE: Hybrid embedding graph neural network for drug side effects prediction

  2022cites this paper
• Chemical Reaction Mining

  2021cites this paper
• Evaluating Drug Risk Using GAN and SMOTE Based on CFDA's Spontaneous Reporting Data

  2021cites this paper
• Predicting potential adverse events using safety data from marketed drugs

  2020cites this paper
• Machine learning-based methods and novel data models to predict adverse drug reaction

  2020cites this paper
• Identifying Herbal Adverse Events From Spontaneous Reporting Systems Using Taxonomic Name Resolution Approach

  2020cites this paper
• Electronic Medical Records and Machine Learning in Approaches to Drug Development

  2020cites this paper
• A comprehensive review of computational techniques for the prediction of drug side effects

  2020cites this paper
• Discovering Links Between Side Effects and Drugs Using a Diffusion Based Method

  2019cites this paper
• Computational chemoproteomics to understand the role of selected psychoactives in treating mental health indications

  2019cites this paper
• Using PubChem’s database with data mining and machine learning algorithms for the prediction of EGFR inhibitors: a comparative study

  2018cites this paper
• Predicting adverse drug reactions through interpretable deep learning framework

  2018cites this paper
• CANDOCK: Chemical atomic network based hierarchical flexible docking algorithm using generalized statistical potentials

  2018cites this paper
• Translational systems pharmacology‐based predictive assessment of drug‐induced cardiomyopathy

  2018influential citation
• Predictive Systems Toxicology.

  2018cites this paper
• Expanding biological space coverage enhances the prediction of drug adverse effects in human using in vitro activity profiles

  2018cites this paper
• A chronological pharmacovigilance network analytics approach for predicting adverse drug events

  2018cites this paper
• Systems Toxicology: Systematic Approach to Predict Toxicity.

  2017cites this paper
• Translational Bioinformatics and Drug Discovery

  2017cites this paper
• Therapeutic Causes of Stevens - Johnson Syndrome - A Mini Review

  2017cites this paper
• Natural Language Processing for EHR-Based Pharmacovigilance: A Structured Review

  2017cites this paper
• Standard-based comprehensive detection of adverse drug reaction signals from nursing statements and laboratory results in electronic health records

  2017cites this paper
• ARWAR: A network approach for predicting Adverse Drug Reactions

  2016cites this paper
• Drug Repurposing Is a New Opportunity for Developing Drugs against Neuropsychiatric Disorders

  2016cites this paper
• Cheminformatics analysis of the AR agonist and antagonist datasets in PubChem

  2016cites this paper
• AZPharm MetaAlert: A Meta-learning Framework for Pharmacovigilance

  2016cites this paper
• In silico assessment of adverse drug reactions and associated mechanisms.

  2016cites this paper
• Exploring Polypharmacology in Drug Discovery and Repurposing Using the CANDO Platform.

  2016cites this paper
• The role of drug profiles as similarity metrics: applications to repurposing, adverse effects detection and drug–drug interactions

  2016cites this paper
• Data-driven Approach to Detect and Predict Adverse Drug Reactions.

  2016cites this paper
• Getting the most out of PubChem for virtual screening

  2016cites this paper
• Network analysis with PubChem BioAssay: Preliminary study on drug abuse

  2016cites this paper
• Cheminformatics-aided pharmacovigilance: application to Stevens-Johnson Syndrome

  2015cites this paper
• Integrating Multiple Evidence Sources to Predict Adverse Drug Reactions Based on a Systems Pharmacology Model

  2015cites this paper
• Using Health-Consumer-Contributed Data to Detect Adverse Drug Reactions by Association Mining with Temporal Analysis

  2015cites this paper
• Large-Scale Predictive Drug Safety: From Structural Alerts to Biological Mechanisms.

  2015cites this paper
• Extraction of Clinical Phenotypic Information from Online Heterogeneous Healthcare Networks

  2015cites this paper
• Combining automatic table classification and relationship extraction in extracting anticancer drug-side effect pairs from full-text articles

  2015cites this paper
• Renal Safety Pharmacology in Drug Discovery and Development.

  2015cites this paper
• Systematic drug safety evaluation based on public genomic expression (Connectivity Map) data: myocardial and infectious adverse reactions as application cases.

  2015cites this paper
• Systems Pharmacology and Pharmacogenomics for Drug Discovery and Development

  2015cites this paper
• The potential of translational bioinformatics approaches for pharmacology research.

  2015cites this paper
• Detection of Drug–Drug Interactions Inducing Acute Kidney Injury by Electronic Health Records Mining

  2015cites this paper
• Determining molecular predictors of adverse drug reactions with causality analysis based on structure learning

  2014cites this paper
• Toward Enhanced Pharmacovigilance Using Patient-Generated Data on the Internet

  2014cites this paper
• Unveiling new biological relationships using shared hits of chemical screening assay pairs

  2014cites this paper
• PubChem applications in drug discovery: a bibliometric analysis.

  2014cites this paper
• Postmarketing Drug Safety Surveillance Using Publicly Available Health-Consumer-Contributed Content in Social Media

  2014cites this paper
• Automatic construction of a large-scale and accurate drug-side-effect association knowledge base from biomedical literature

  2014cites this paper
• An efficient algorithm coupled with synthetic minority over-sampling technique to classify imbalanced PubChem BioAssay data.

  2014cites this paper
• Role of text mining in early identification of potential drug safety issues.

  2014cites this paper
• Traditional Chinese Medicine-Based Network Pharmacology Could Lead to NewMulticompound Drug Discovery

  2014cites this paper
• Integrating Domain Knowledge to Improve Signal Detection from Electronic Health Records for Pharmacovigilance

  2014cites this paper
• Identification and mechanistic investigation of clinically important myopathic drug-drug interactions

  2014cites this paper
• Predicting putative adverse drug reaction related proteins based on network topological properties

  2014cites this paper
• Web search and data mining of natural products and their bioactivities in PubChem.

  2013cites this paper
• Artificial Intelligence Approaches for Drug Safety Surveillance and Analysis

  2013cites this paper
• Adverse Drug Events: Database Construction and in Silico Prediction

  2013cites this paper
• Predicting adverse drug reaction profiles by integrating protein interaction networks with drug structures

  2013cites this paper
• Computational Drug Repositioning: From Data to Therapeutics

  2013cites this paper
• The coming age of data-driven medicine: translational bioinformatics' next frontier

  2012cites this paper
• Translational Bioinformatics: Data‐driven Drug Discovery and Development

  2012cites this paper
• Drug discovery in the age of systems biology: the rise of computational approaches for data integration.

  2012cites this paper
• Social media mining for drug safety signal detection

  2012cites this paper
• Traditional Chinese Medicine-Based Network Pharmacology Could Lead to New Multicompound Drug Discovery

  2012cites this paper
• Established and emerging trends in computational drug discovery in the structural genomics era.

  2012cites this paper
• The impact of network biology in pharmacology and toxicology

  2012cites this paper
• Automatically Detecting Workflows in PubChem

  2012cites this paper
• Translational Bioinformatics Embraces Big Data

  2012cites this paper
• Novel Data‐Mining Methodologies for Adverse Drug Event Discovery and Analysis

  2012influential citation
• Characterizing protein domain associations by Small-molecule ligand binding.

  2012cites this paper
• Large-scale prediction of adverse drug reactions using chemical, biological, and phenotypic properties of drugs

  2012cites this paper
• Detecting Signals of Adverse Drug Reactions from Health Consumer Contributed Content in Social Media

  2012cites this paper
• Data mining methodologies for pharmacovigilance

  2012cites this paper
• Systematic Drug Repositioning Based on Clinical Side-Effects

  2011cites this paper
• A Network Biology Approach to Predicting Drug Cardiotoxicity

  2011cites this paper
• Predicting adverse side effects of drugs

  2011cites this paper
• Principles of Safety Pharmacology

  2008cites this paper